Johane Allard: Clinical Trials

10 trials sponsored by Johane Allard, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 terminated, 1 unknown. 4 Phase 2, 2 Phase 4, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Terminated 1
Phase 42Completed 2
Phase 31Terminated 1

Follow Johane Allard: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Stool Transplantation for Treatment of Insulin Resistance in Morbidly Obese Patients
Fecal filtrate from 150 g stool from healthy lean donors, Fecal filtrate from 150 g of the recipient's own stool - Obesity, Morbid, Insulin Resistance
Phase 2CompletedJohane Allard292017-03-012025-04-24
Comparison of Two Intravenous Lipid Emulsions in Home Parenteral Nutrition Patients
SMOFlipid20% - Home Parenteral Nutrition
Phase 4CompletedJohane Allard502016-03-012020-03-24
Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils
Intralipid, ClinOleic - Obstruction, Cancer
Phase 4CompletedJohane Allard3032013-07-012025-02-03
Intestinal Microbiota and NAFLD Pre and Post Bariatric Surgery
Morbid Obesity, Non-alcoholic Fatty Liver Disease
UnknownJohane Allard1202013-06-012022-11-02
Fish Oil for Patients With Liver Disease Due to Parenteral Nutrition
Soybean oil (Standard treatment), Soybean oil + Fish oil - Total Parenteral Nutrition-induced Cholestasis
Phase 3TerminatedJohane Allard22012-02-012016-05-12
Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)
Omega-3 capsules-Fish Oil - Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis
Phase 2CompletedJohane Allard202009-10-012016-05-12
Oxidative Stress and Fatty Acids in Hepatitis C
Hepatitis C, Hepatic Steatosis
CompletedJohane Allard1052005-07-012014-01-10
Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions
antioxidant vitamin E, weight reduction and exercise - HIV Infections, Fatty Liver
Phase 2TerminatedJohane Allard302003-10-012013-07-19
Fatty Acids, Genes and Microbiota in Fatty Liver
Nonalcoholic Fatty Liver Disease, Steatosis
CompletedJohane Allard2052003-10-012016-05-12
To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities
chromium nicotinate, Placebo - HIV Infections
Phase 2CompletedJohane Allard522002-08-012013-07-19

Conditions studied

Fatty Liver (4)  ·  Non-alcoholic Fatty Liver Disease (4)  ·  HIV Infections (2)  ·  Hyperphagia (2)  ·  Inflammation (2)  ·  Obesity, Morbid (2)  ·  Anxiety Disorders (1)  ·  Bites and Stings (1)  ·  Catheter-Related Infections (1)  ·  Depression (1)  ·  Hepatitis C (1)  ·  Ileus (1)  ·  Infections (1)  ·  Insulin Resistance (1)  ·  Liver Diseases (1)

Interventions

soybean oil, phospholipid emulsion (2)  ·  ClinOleic (1)  ·  Exercise (1)  ·  Fish Oils (1)  ·  Soybean Oil (1)  ·  chromium nicotinic acid complex (1)  ·  fish oil triglycerides (1)

Countries

Canada (10)

Top investigators

Johane P Allard, MD, FRCPC (3)  ·  Allard Johane, MD, FRCPC (1)  ·  Johane P Allard, MD (1)  ·  Johane P Allard, MD,FRCPC (1)

Results publications

PMID 18086506, PMID 18288980, PMID 19211827, PMID 20163347, PMID 23401313, PMID 23537027, PMID 24631112, PMID 25581263, PMID 35166723, PMID 37081524, PMID 38353022, PMID 39624175